Wikidata

(Q44787221)

English

CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy

scientific article published in March 2004

In more languages

Statements

title
CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15001971
retrieved
6 December 2017
author name string
Marta Spreafico
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15001971
retrieved
6 December 2017
Simona Maria Siboni
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15001971
retrieved
6 December 2017
Marco Moia
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15001971
retrieved
6 December 2017
publication date
1 March 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15001971
retrieved
6 December 2017
page(s)
198-203
1 reference
stated in
Europe PubMed Central
PubMed ID
15001971
retrieved
6 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44787221&oldid=2041994996"